Drugdiscovery >> Clinical Trials >> News
3435
Views
Incyte's new drug produced promising results for Polycythemia Vera - drugdiscovery.com
Incyte's new drug produced promising results for Polycythemia Vera - drugdiscovery.com


Incyte's Polycythemia Vera drug produced far better results on clinical Phase III trials than the former alternatives of medicine for patients who are resistant to or intolerant of hydroxyurea.
Read More >>


Tags: hydroxyurea, Incyte, Polycythemia Vera - March 7, 2014
Related Articles
3540
Views
Experimental durg of  Pfizer gives promising results in prevention of community acquired pneumonia Experimental durg of Pfizer gives promising results in prevention of community acquired pneumonia
Pfizer has just finished its landmark stuy over a pnemonia drug. The trial which is based on over 85,000 samples and the new treatment seems to be very effective on patient 65 years and over. Read More >>

Tags: drug; discovery, development, news, Pfizer, CAPITA, clinical trial, CAP, pneumonia, primary endpoint

7362
Views
Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS Promising results in Phase II clinical trials of Tirasemtiv in patients with ALS
Cytokinetics’ drug Tirasemtiv, a fast skeletal muscle troponin activator, shows safe and tolerable in two prior Phase 2 trials in patients with amyotrophic lateral sclerosis (ALS). The compound is Read More >>

Tags: Tirasemtiv, ALS, clinical trial, skeletal muscle troponin activator, amyotrophic lateral sclerosis, Cytokinetics

8039
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

5878
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

4614
Views
Ventrus’ drug for anal fissures shows positive clinical results Ventrus’ drug for anal fissures shows positive clinical results
Diltiazem hydrochloride 2% cream (VEN 307) has been successful in two clinical dermal safety studies and one pharmacokinetic (PK) study. This paves way to new drug application (NDA) for VEN 307 as a t Read More >>

Tags: Ventrus, VEN 307, anal fissures, cream, new treatment, clinical trials

4644
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

4167
Views
The results of linagliptin safety trials in patients with type 2 diabetes The results of linagliptin safety trials in patients with type 2 diabetes
Eli Lilly and Boehringer Ingelheim presented the results from two pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the linagliptin in adults with type 2 di Read More >>

Tags: lingliptin, type 2 diabetes, safety, clinical trials, Eli Lilly

4702
Views
Promising new therapy for  Duchenne muscular dystrophy patients Promising new therapy for Duchenne muscular dystrophy patients
In the first study from a double-blind controlled randomized trial, Sarepta Therapeutics’ drug eteplirsen, improved walking performance of DMD patients. Although the first results are promising, f Read More >>

Tags: Duchenne muscular dystrophy, clinical trials, DMD,Sarepta Therapeutics, eteplirsen

5177
Views
Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial Humira as a treatment for hidradenitis suppurativa- the results of Phase 2 trial
According to the results of Phase 2 clnical trial, Humira induced a significant response rate, compared to placebo, in adult patients with moderate-to-severe hidradenitis suppurativa (HS). The drug Read More >>

Tags: Humira, AbbVie, hidradenitis suppurativa, clinical trial

3105
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013